Exosomes have been intensively studied in autoimmune diseases, and circulating exosomes and microvesicles have also been explored in autoimmune thyroiditis (AITD). However, the role of thyroid cell-derived exosomes in immune responses is unclear. We showed that IFN-γ-treated Nthy-ori 3-1 cell-derived exosomes (IFN-γ-Exo) harbored TPO, HSP60 and MHC-II and activated dendritic cells (DCs) in vitro. Compared with Exo-targeted DCs (DC Exo ), IFN-γ-Exo-targeted DCs (DC IFN-γ-Exo ) promoted the expression and release of proinflammatory cytokines, such as IFN-γ, IL-17A and IL-22, from CD4+ T lymphocytes and inhibited the expression and release of anti-inflammatory cytokines, such as IL-4, IL-10 and TGF-β1; however, IFN-γ-Exo did not have this effect compared with Nthy-ori 3-1 cell-derived exosomes (Exo). DC IFN-γ-Exo stimulates the expression and release of cytokines from CD4+ T lymphocytes more efficiently than IFN-γ-Exo. Thus, DC IFN-γ-Exo may effectively induce CD4+ T lymphocyte-mediated immune responses and play a role in the occurrence and development of AITD. Abbreviations AITD: autoimmune thyroiditis HT: Hashimoto thyroiditis Highlights 1.IFN-γ-treated thyroid cell-derived exosomes (IFN-γ-Exo) express TPO, HSP60, MHC-II. 2.IFN-γ-Exo activate dendritic cells (DCs).
Hashimoto thyroiditis (HT) is an autoimmune thyroid disorder (AITD) characterized by the breakdown of self-tolerance to thyroid antigens, resulting in local lymphocyte infiltration and an increased antibody titer in the circulation. This infiltration leads to apoptosis of thyroid cells and hypothyroidism in HT (Dayan and Daniels, 1996) .
Exosomes are small vesicles with a lipid bilayer and a diameter of 30-100 nm that are released by many types of cells under physiological and pathological conditions; exosomes contain components from the mother cell, such as proteins, DNA fragments, mRNAs, microRNAs and long noncoding RNAs (Shah et al., 2018) . Therefore, exosomes play a role in intercellular communication at the site where they are secreted and at distant sites after their release into the circulation, urine and ascites; subsequently, these secreted exosomes participate in the occurrence and development of various autoimmune diseases (Tan et al., 2016; Turpin et al., 2016) .
It has become clear that dendritic cells (DCs), as the most powerful professional antigen-presenting cells (APCs), and CD4+ T lymphocytes, as the main cells involved in the inflammatory response, are involved in the pathogenesis of HT (Ramos-Levi and Marazuela, 2016) . Naive CD4+ T lymphocytes are activated when they are presented peptide antigens by MHC-II, which is expressed on professional APCs or on nonprofessional APCs, such as thyroid follicular cells (TFCs) (Davies and Piccinini, 1987; Pyzik et al., 2015) . APC-derived exosomes play a role in antigen presentation and T lymphocyte activation (Tkach et al., 2017) , but the role 6 of nonprofessional APC-derived exosomes, such as thyroid cell-derived exosomes, in these processes has been described in very few settings.
IFN-γ is a major inflammatory cytokine that is produced by T helper 1 (Th1) lymphocytes and plays an important role in the occurrence and development of HT (Pyzik et al., 2015) , and IFN-γ has been shown to be the most potent cytokine and uesd to stimulate thyroid cell lines in the study of autoimmune thyroiditis (AIT) (Guo et al., 2018) . Therefore, we aimed to explore whether exosomes released from IFN-γ-stimulated thyroid cells can carry antigens, antigen-presenting molecules, and inflammatory factors, such as TPO, HSP60 and MHC-II, perform antigen-presenting and proinflammatory functions and directly induce CD4+ T lymphocyte-mediated adaptive immune responses, which may provide a new perspective for interpreting the pathogenesis of HT.
Material and Methods

Ethics Statement
The blood samples used in this study were from healthy female donors (age range: 25-50 years, with no acute infection, no thyroid or chronic disease, no pregnancy and no smoking). Informed consent was obtained from all subjects. The human ethics protocol was approved by the Ethics Committee of China Medical University (ethical approval number: 2017-92-2). 7
Culture of Thyroid Cells
The human thyroid follicular epithelial cell line (Nthy-ori 3-1) was obtained from Prof. Hao Zhang, Department of Thyroid Surgery of the First Hospital of China Medical University. Cells were cultured in RPMI 1640 medium (Solarbio Life Science, China) supplemented with 10% exosome-depleted fetal bovine serum (PAN, Germany) and 1% penicillin-streptomycin (HyClone, USA) for 48-72 h until 90% confluence was reached, after which the cell supernatant was collected. According to the results of the preliminary experiment, the Nthy-ori 3-1 cell line was treated with 500 IU/ml recombinant human IFN-γ (285-IF-100, R&D Systems, USA).
Coculture of Thyroid Cells and DCs
To clarify whether exosomes are involved in the process of DC activation induced by thyroid cells, Nthy-ori 3-1 cells were cocultured with DCs in a Transwell-6 system with a 0.4-µm porous membrane (Biofil, China) to prevent both the transfer of vesicles larger than exosomes and direct cell contact. The DCs were plated in the lower wells, and Nthy-ori 3-1 cells or 500 IU/ml IFN-γ-stimulated Nthy-ori 3-1 cells were then plated in the upper wells. After 24 h of coculture, DCs were collected for flow cytometry assays and cytokine mRNA measurement. GW4869 (Sigma, USA), a well-known inhibitor of exosome generation (Essandoh et al., 2015) , was used to reduce the release of exosomes from Nthy-ori 3-1 cells. In the GW4869 inhibitor experiment, before Nthy-ori 3-1 cells were cocultured with DCs, they were stimulated with 10 µM GW4869 for 8 h. GW4869 was initially dissolved in DMSO (Fisher Scientific, USA) to generate a stock solution before dilution in culture supernatant to achieve a 10 µM GW4869 concentration in cell culture conditions.
Exosome Isolation
Small extracellular vesicles (including exosomes) were extracted from the culture medium of Nthy-ori 3-1 cells or IFN-γ-treated Nthy-ori 3-1 cells by differential centrifugation (Thery et al., 2006) . Briefly, the medium was centrifuged at 300 x g for 10 min and 2000 x g for 10 min to eliminate cells. Then, the supernatant was centrifuged at 10,000 x g for 30 min to remove cell debris. After filtration through a 0.22 µm polyvinylidene difluoride (PVDF) membrane, the supernatant was transferred to a new tube and centrifuged at 100,000 x g for 70 min at 4°C to isolate small extracellular vesicles (including exosomes). The resulting pellet was washed, resuspended in 40 ml of PBS and recentrifuged at 100,000 x g for 70 min at 4°C to eliminate contaminating proteins. The final pellet was resuspended in 300 µl of PBS and stored at -80°C.
Exosome-free fetal bovine serum was obtained by ultracentrifugation at 100,000 × g at 4°C for 16 h.
Transmission Electron Microscopy (TEM)
The small extracellular vesicles (including exosomes) were diluted in PBS, applied to carbon-coated grids, and negatively stained with 3% (w/v) aqueous phosphotungstic acid, and images were obtained with a transmission electron microscope (Tecnai G2 Spirit, FEI, USA).
Nanoparticle Tracking Analysis (NTA)
The small extracellular vesicles (including exosomes) were diluted in PBS. The size of the exosomes was analyzed using an NS300 NTA instrument (NanoSight, Malvern Instruments Ltd., UK) following the manufacturer's instructions.
Western Blot Analysis
Proteins were extracted from the small extracellular vesicles (including exosomes) using RIPA lysis buffer (Beyotime, China) containing a protease inhibitor cocktail. The protein concentration was measured using a BCA Protein Assay kit (Beyotime, China). The specific steps of Western blot analysis were performed according to another study (Guo et al., 2018) . The antigens detected in small extracellular vesicles (including exosomes) were GAPDH, CD63, TG, TPO, HSP60, HMGB1, MHC-II, and ICAM1. The antibodies used in this experiment were as previously described (Cui et al., 2019) . As indicated by Western blot, small extracellular vesicles (including exosomes) highly expressed the exosomal marker CD63. Therefore, in subsequent studies, small extracellular vesicles (including exosomes) were called exosomes. Nthy-ori 3-1 cell-derived exosomes were defined as Exo, and IFN-γ-treated Nthy-ori 3-1 cell-derived exosomes were defined as IFN-γ-Exo.
In Vitro Stimulation of DCs
10 CD14+ monocytes in the PBMC populations from healthy female donors were isolated using a Mojosort TM Human CD14 Selection kit (480026, BioLegend, USA) according to the manufacturer's instructions, and the sorting rate was detected by flow cytometry (CD14-PerCP (325622), BioLegend, USA). To obtain DCs, sorted CD14+ monocytes were cultured for 5 days in RPMI 1640 medium supplemented with 10% exosome-depleted fetal bovine serum, 1% penicillin-streptomycin, 100 ng/ml and 100 ng/ml GM-CSF (300-03-20) (both from PeproTech, USA). The percentage of CD11c+ DCs was detected by flow cytometry (CD11c-APC (301614), BioLegend, USA). DCs were cocultured with 100 µg/ml Exo or IFN-γ-Exo for 24 h. After 24 h, DCs were stained with the corresponding fluorescently labeled Abs (CD40-FITC (334306), CD80-APC (305220) and CD83-PE (305308) (all from BioLegend, USA)) on ice for 30 min, and the expression levels of CD40, CD80 and CD83 on DCs were detected by a BD FACS Array Analyzer (Becton Dickinson, USA). The isotype control antibody used refers to a previously published article (Cui et al., 2019) . Total RNA was extracted from DCs with TRIzol reagent, and the mRNA expression of TNF and IL-6 was detected by RT-PCR.
To stimulate CD4+ T lymphocytes, exosome-stimulated DCs were cocultured with CD4+ T lymphocytes, and the exosomes used to stimulate DCs were cleared with the DC suspension by centrifugation. Exo-stimulated (targeted) DCs were defined as DC Exo, and IFN-γ-Exo-stimulated (targeted) DCs were defined as DC IFN-γ-Exo.
In Vitro Stimulation of CD4+ T Lymphocytes
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CD4+ T lymphocytes in the PBMC populations from healthy female donors were isolated using a Mojosort TM Human CD4 Selection kit (265209, BioLegend, USA) according to the manufacturer's instructions, and the sorting rate was examined with flow cytometry (CD4-PE (300508), BioLegend, USA). Sorted CD4+ T lymphocytes were cultured for 6 days in RPMI 1640 medium supplemented with 10% exosome-depleted fetal bovine serum and 1% penicillin-streptomycin in a plate precoated with 5 µg/ml anti-CD3 (317315) and 2 µg/ml anti-CD28 antibodies (302923) (both from BioLegend, USA) and then cocultured with Exo, IFN-γ-Exo, DC Exo or DC IFN-γ-Exo for 24 h. For Th17 and Treg cell differentiation, refer to the literature (Cui et al., 2019) . Total RNA was extracted from cells with TRIzol reagent, and the mRNA expression of cytokines was evaluated by RT-PCR. The cell supernatant was collected and stored at -80°C for cytokine detection using an enzyme-linked immunosorbent assay (ELISA).
Real-Time Quantitative Polymerase Chain Reaction (RT-PCR)
The specific procedures for total RNA extraction and RT-PCR were performed according to another study (Guo et al., 2018) . GAPDH was used as the internal control for mRNA. The 
ELISA
Cell supernatants were collected, and the concentrations of IFN-γ, IL-17A and IL-10 in the supernatants were measured using ELISA kits according to the manufacturer's instructions (IFN-γ (BMS228HS), IL-17A (BMS2017HS) and IL-10 (BMS215HS), all from Invitrogen Corp., USA).
Statistical Analyses
Normally distributed data are presented as the mean±SEM and compared using Student's t-test between two groups or compared using ANOVA among three or more groups; nonnormally distributed parameters are expressed as the median (interquartile range) (IQR) and compared using the Kruskal-Wallis H-test among three or more groups. Each experiment was repeated at least three times. P < 0.05 was considered significant.
Results
Increased Protein Expression of TPO, HSP60 and MHC-II in IFN-γ-Exo
First, we extracted and identified Exo and IFN-γ-Exo, and TEM, NTA, and Western blot results showed that we successfully isolated exosomes from the cell supernatant, TEM and NTA results of Exo, as controls for IFN-γ-Exo, are not shown in the figure (Fig. 1A-C ). Then, we analyzed the expression of TPO, Tg, HSP60, HMGBI, MHC-II, ICAM1 and the exosomal marker CD63 in Exo and IFN-γ-Exo by Western blot. Representative blots are shown in Fig. 1C . Compared with those in Exo, the protein expression levels of TPO, HSP60 and MHC-II were significantly increased in IFN-γ-Exo (P=0.015, 0.025 and 0.026, respectively; Fig. 1D ), and the protein expression levels of other indicators were not different between the two groups. 
IFN-γ-Exo Activate DCs
After sorting, the percentage of CD14+ monocytes was greater than 90%, and the percentage of CD11c+ DCs was greater than 95% after 5 days of culture ( Fig. 2A ). After coculturing Exo or IFN-γ-Exo with DCs for 24 h, compared with Exo, IFN-γ-Exo significantly increased the expression of the costimulatory factors CD40 and CD80 and the mature marker CD83 on DCs (P=0.013, 0.009 and 0.036, respectively) ( Fig. 2B) . Compared with Exo, IFN-γ-Exo significantly increased the mRNA expression levels of IL-6 and TNF in DCs (P<0.001 and 0.026, respectively) ( Fig. 2C) . These results indicate that IFN-γ-Exo could activate DCs. DCs were incubated with PBS or cocultured with Exo or IFN-γ-Exo for 24 h.
(A). The sorting rate of CD14+ monocytes was above 90%. After sorting, CD14+ monocytes were cultured in 3 ml of medium supplemented with IL-4 (100 ng/ml) and GM-CSF (100 ng/ml) in 6-well plates. DCs were harvested after 5 days of culture. The percentage of CD11c+ DCs was above 95%. The blue shaded area represents the isotype control. The experiment was repeated five times, and a representative experiment is shown. Exo: Nthy-ori 3-1 cell-derived exosomes; IFN-γ-Exo: IFN-γ-treated Nthy-ori 3-1 cell-derived exosomes. Data are pooled from at least 3 independent experiments. All the data in this section fit a normal distribution, are expressed as the mean ± SEM and were compared by ANOVA. *P <0.05, **P < 0.01.
Inhibition of IFN-γ-Exo Release Partially Reduces Costimulatory Factors and Proinflammatory Cytokines Expression in DCs
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After coculturing Thy, IFN-γ-Thy with DCs for 24 h, compared with Thy, IFN-γ-Thy significantly increased the mRNA expression levels of IL-6 and TNF in DCs (P=0.029 and 0.016, respectively) ( Fig. 3A ) and the expression of the costimulatory factors CD40 and CD80 and the mature marker CD83 on DCs (P=0.023, 0.005 and 0.045, respectively) ( Fig. 3B) . GW4869 attenuated the increase in the mRNA expression levels of IL-6 and TNF in DCs (P=0.007 and 0.01, respectively) ( Fig. 3A ) and the expression of the costimulatory factors CD40 and CD80 and the mature marker CD83 on DCs caused by IFN-γ-Thy (P<0.001, 0.017 and 0.045, respectively) ( Fig. 3B) . These data suggest that IFN-γ-stimulated thyroid cells contribute to DC activation and that exosomes might be involved in this process. Thy: Nthy-ori 3-1 cells; IFN-γ-Thy: IFN-γ-treated Nthy-ori 3-1 cells. GW4869 was used to inhibit the production of exosomes from Nthy-ori 3-1 cells. PBS and DMSO were used as controls. Data are pooled from at least 3 independent experiments. Normally distributed data are expressed as the mean ± SEM and were compared by ANOVA, and nonnormally distributed data are expressed as the median (interquartile range) (IQR) and were compared by the Kruskal-Wallis H-test. *P <0.05, **P < 0.01.
IFN-γ-Exo Cannot Directly Induce the Expression and Release of Cytokines in CD4+ T
Lymphocytes
After sorting, the percentage of CD4+ T lymphocytes was greater than 90% (Fig. 4A ). CD4+ T lymphocytes were incubated with PBS or cocultured with Exo or IFN-γ-Exo for 24 h, and the findings showed that compared with PBS, Exo reduced the mRNA expression level of TGF-β1 in CD4+ T lymphocytes (P=0.022), IFN-γ-Exo decreased the mRNA expression levels of IL-10 and TGF-β1 in CD4+ T lymphocytes (P=0.009 and 0.03, respectively) and increased the protein expression level of IFN-γ in the supernatant (P=0.025). Compared with Exo, IFN-γ-Exo tended to promote the expression and release of proinflammatory cytokines in CD4+ T lymphocytes and inhibit the expression and release of anti-inflammatory cytokines in CD4+ T lymphocytes, but there was no difference between the two groups ( Fig. 4B and C) . We suspected that although IFN-γ-Exo express MHC-II, they do not directly cause inflammatory responses in CD4+ T lymphocytes and may also require the presentation of APCs, such as DCs. 
IFN-γ-Exo-Stimulated DCs are Indispensable for the Expression and Release of Cytokines in CD4+ T Lymphocytes
DCs were stimulated with exosomes for 24 h and then cocultured with autologous CD4+ T lymphocytes for 24 h. The findings showed that compared with DC Exo , DC IFN-γ-Exo markedly increased the mRNA expression levels of IFN-γ and IL-17A (P<0.001 and 0.002, respectively) in CD4+ T lymphocytes and increased the concentrations of IFN-γ and IL-17A (P<0.001 and 0.03, respectively) in the supernatant. In contrast, compared with DC Exo , DC IFN-γ-Exo greatly decreased the mRNA expression levels of IL-10 and TGF-β1 (P=0.029 and 0.036, respectively) in CD4+ T lymphocytes and decreased the concentrations of IL-10 (P=0.047) in the supernatant (Fig. 5A and B) . Next, we compared the ability of IFN-γ-Exo and DC IFN-γ-Exo to induce the expression and release of cytokines in CD4+ T lymphocytes. The mRNA expression levels of IFN-γ, IL-17A, IL-22, IL-4, IL-10 and TGF-β1 (P=0.002, 0.001, 0.025, 0.011, 0.01 and 0.011, respectively) and supernatant concentrations of IFN-γ, IL-17A and IL-10 (P=0.004, 0.02 and 0.008, respectively) were markedly higher in CD4+ T lymphocytes cocultured with DC IFN-γ-Exo than in CD4+ T lymphocytes cocultured with IFN-γ-Exo ( Fig. 5C and D) . These results suggest that activated DCs, particularly after previous incubation with IFN-γ-Exo, are necessary for the expression and release of cytokines in CD4+ T lymphocytes. 
Discussion
Recent studies have shown that internal (i.e., genetic and epigenetic alterations) and external (i.e., radiation, iodine, smoking, infection, stress and drugs) factors and cellular and molecular alterations are all involved in the pathogenesis and progression of AITD (Ajjan and Weetman, 2015; Antonelli et al., 2015) . Our previous research (Cui et al., 2019) confirmed that serum exosomes from patients with HT can activate DCs and promote the differentiation of CD4+ T lymphocytes in PBMCs into proinflammatory cells. However, in this article, we conducted a more detailed study, imitating the inflammatory infiltrating thyroid cells from patients with HT with IFN-γ-stimulated thyroid cells and sorting DCs and CD4+ T lymphocytes from PBMCs, to further explore the role of thyroid cell-derived exosomes in the pathogenesis of HT. This study confirmed for the first time that IFN-γ-stimulated-thyroid cell-derived exosomes contain TPO, MHC-II and HSP60 and need to activate DCs before they can further cause an imbalance in the expression and secretion of cytokines of CD4+ T lymphocytes and participate in the occurrence and development of HT. GW4869, which inhibits the generation of thyroid cell-derived exosomes, can partially inhibit the activation of DCs.
Exosomes are membrane-bound vesicles that are released into the extracellular space when a multivesicular body fuses with the plasma membrane. Exosomes harbor membrane and 21 cytosolic proteins that are derived from their parental cells. Exosomes derived from APCs have been reported to contain MHC-II, ICAM-1, CD80 and CD86, which are essential for antigen presentation (Clayton et al., 2001; Zhang et al., 2014) . Furthermore, mature DC-derived exosomes have been shown to induce the proliferation of CD4+ T cells in an antigen-specific manner (Segura et al., 2005) . Another study showed that microparticles from TNF-and IFN-γ-stimulated endothelial cells increased the expression of important molecules for antigen presentation and T lymphocyte stimulation, such as MHC-II, CD40 and ICAM1, and bound to an increased proportion of T lymphocytes (Wheway et al., 2014) . Cianciaruso C found that rat and human pancreatic islets release intracellular β-cell autoantigens, such as GAD65, IA-2 and proinsulin, in exosomes, which are taken up by and activate DCs. Compared to exosomes from untreated islets, exosomes isolated from human islets treated with IL-1β and IFN-γ induced a greater level of secretion of the immunostimulatory cytokines IL-6 and TNF-α from bone marrow-derived dendritic cells (BMDCs) (Cianciaruso et al., 2017) . Here, our findings suggest that exosomes derived from thyroid cells treated with IFN-γ carry antigens, antigen-presenting molecules and inflammatory factors, such as TPO, MHC-II and HSP60, and may induce innate immune responses in DCs.
Since TFCs, as nonprofessional APCs, could directly present antigens to CD4+ T lymphocytes, we explored whether exosomes derived from IFN-γ-stimulated thyroid cells could also directly present antigens to activate CD4+ T lymphocytes without the involvement of DCs.
Our data showed that DC IFN-γ-Exo , but not IFN-γ-Exo, caused abnormal expression and secretion of cytokines from CD4+ T lymphocytes. It is possible that IFN-γ-Exo carrying MHC-II antigens and proinflammatory signals may be particularly immunogenic. DCs that take up IFN-γ-Exo gain antigen specificity from these IFN-γ-Exo and then become immunogenic and capable of stimulating CD4+ T lymphocyte-mediated immune responses. The stimulatory effect of these DCs is stronger than that of IFN-γ-Exo . In addition, many non-MHC-II molecules, such as the costimulatory molecules CD40, CD80 and CD86, are also required for the activation of CD4+ T lymphocytes. It has been reported that the expression of the costimulatory molecules CD40 and CD80 in mature DC-derived exosomes was lower than that in mature DCs (Hao et al., 2007) .
IFN-γ-induced thyroid cells are nonprofessional antigen-presenting cells, and their expression of costimulatory molecules is speculated to be much lower than that in mature DCs, so we suspect that the expression of CD40, CD80 and CD83 in IFN-γ-stimulated thyroid cell-derived exosomes may also be lower than that in mature DCs. A large number of studies have shown that DCs play an important role in the involvement of exosomes in the immune response. A previous study showed that even high concentrations of exosomes carrying the male H-Y antigen (Dby) failed to stimulate the proliferation of naive Dby-specific T cells unless DCs were added (Thery et al., 2002) . Compared with EG7 tumor cell-derived exosomes (EXO EG7 ), EXO EG7 -targeted DCs could efficiently induce antitumor immunity (Yao et al., 2013) . A more interesting research report showed that mature DCs pulsed with EXOOVA (mDCEXOs) could induce ovalbumin (OVA)-specific cytotoxic T lymphocyte responses, antitumor immunity and CD8+ T cell memory more efficiently than OVA protein-pulsed DCs (DCOVA) and DCOVA-derived Exos 23 (EXOOVA) in vivo (Hao et al., 2007) . In general, these findings suggest that DCs are indispensable for the induction of T lymphocyte-mediated adaptive immune responses by exosomes.
Inflammatory regulation or cytokine balance, such as Th1/Th2 and Th17/Treg balance, plays a key role in HT pathogenesis (Rydzewska et al., 2018) . Mature-naive T cells differentiate into distinct subsets of T cells, including proinflammatory T helper (Th)1 and Th17 cells and anti-inflammatory Th2 and Treg cells. Th1 cells produce IFN-γ, IL-1 and IL-2; Th2 cells secrete mainly IL-4, IL-5, IL-6, IL-10 and IL-13; Th17 cells secrete IL-17A, IL-17F, IL-21 and IL-22;
and Treg cells produce TGF-β, IL-10 and IL-35 (Ramos-Levi and Marazuela, 2016) . It has been previously reported that extracellular vesicles (EVs) can regulate the balance of inflammatory cells or cytokines. Microvesicles from AITD patients inhibit the in vitro differentiation of Foxp3+ Treg cells and induce the expression of IFN-γ by CD4+ lymphocytes, as well as the differentiation of pathogenic Th17 (IL-17+ IFN-γ+) cells (Rodriguez-Munoz et al., 2015) . A previous study showed that circulating exosomes from patients with multiple sclerosis suppress the induction of regulatory T cells (Kimura et al., 2018) . A previous report indicated that OVA plus LPS-induced EVs derived from bronchoalveolar lavage fluid could increase the numbers of Th1 and Th17 cells and corresponding cytokine production from lung CD4+ T cells (Shin et al., 2010) .
In the thyroid tissue of patients with HT, Th1 lymphocytes are the predominant inflammatory infiltrating cells, which may be responsible for enhanced IFN-γ. We suspect that inflammatory cytokines (including IFN-γ) and other factors (including iodine, radiation, infection, etc.) may promote the release of "abnormal exosomes" from thyroid cells in vivo.
These exosomes may activate DCs locally in the thyroid or move to the draining lymph nodes and enter the peripheral lymph and circulation with the lymph fluid to activate distant DCs; the activated DCs may further stimulate CD4+ T lymphocytes to release cytokines (including IFN-γ), which could result in the formation of an inflammatory environment in thyroid tissue and throughout the body. These inflammatory microenvironments could further promote the release of "abnormal exosomes" from thyroid cells in vivo, forming a positive feedback loop involved in the pathogenesis of HT.
A weakness of this study is that primary thyrocyte-derived exosomes from patients with HT were not used for research. Primary thyrocytes need to be obtained from thyroiditis tissue around the lesion, such as thyroid cancer or benign thyroid adenoma, in patients with HT who are undergoing thyroid surgery. For ethical reasons, the amount of thyroiditis tissue obtained during surgery is usually small and not sufficient for subsequent exosome extraction. Although thyroid cells are the main damaged cells in HT and IFN-γ is the main inflammatory factor, other types of cell-derived exosomes and exosomes released by thyroid cells stimulated by other inflammatory factors may also participate in the pathogenesis of HT, which deserves further research.
Conclusions
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Overall, our findings together indicate that in the inflammatory environment, thyrocyte-derived exosomes carrying important molecules for the immune response, including TPO, HSP60 and MHC-II, need to activate DCs before triggering CD4+ T lymphocyte-mediated adaptive immune responses. These findings present a novel mechanism of thyrocyte-derived exosome action in immune and inflammatory responses in HT.
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